| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arrowhead Pharmaceuticals, Inc. (ARWR) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. ARWR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.79M | $311.00M | - | |
| COO | 473.3K | $38.81M | - | |
| Other | 227.0K | $18.61M | - | |
| CFO | 162.9K | $13.36M | - | |
| Dir | 123.1K | $10.09M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 26, 2019 | Ferrari Mauro71 | Director | Sell | 17,756 | $27.61 | $490,243.16 | -90.3% | |
| May 28, 2019 | O'Brien Patrick76 | General Counsel | Sell | 30,000 | $24.88 | $746,400.00 | -12.9% | |
| May 21, 2019 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sell | 27,071 | $22.00 | $595,562.00 | -8.9% | |
| Apr 3, 2019 | Anzalone Christopher Richard60 | Chief Executive Officer | Sell | 50,000 | $19.30 | $965,000.00 | -2.3% | |
| Mar 1, 2019 | Given Bruce D | Chief Operating Officer | Sale+OE | 42,500 | $19.99 | $849,575.00 | -6.2% | |
| Feb 26, 2019 | Given Douglas B66 | Director | Sale+OE | 68,000 | $19.20 | $1,305,400.00 | -16.3% | |
| Feb 25, 2019 | Given Bruce D | Chief Operating Officer | Sale+OE | 42,500 | $18.98 | $806,650.00 | -6.2% | |
| Feb 19, 2019 | Myszkowski Kenneth Allen68 | Chief Financial Officer | Sale+OE | 8,000 | $18.00 | $144,000.00 | -2.6% | |
| Feb 19, 2019 | Given Bruce D | Chief Operating Officer | Sale+OE | 68,750 | $17.86 | $1,227,987.50 | -5.1% | |
| Feb 12, 2019 | Given Bruce D | Chief Operating Officer | Sale+OE | 242,834 | $16.04 | $3,894,247.00 | -7.8% |